L-dopa related hyperhomocysteinemia and development of dementia in Parkinson's disease

被引：0
|
作者：
dell'Aquila, C.
Zoccolella, S.
Mascolo, L.
Abruzzese, G.
Antonini, A.
Bonuccelli, U.
Dlazio, G.
Pacchetti, C.
Lamberti, P.
机构：
来源：
MOVEMENT DISORDERS | 2008年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
760
引用
收藏
页码：S249 / S249
页数：1
相关论文
共 50 条
  • [31] L-DOPA-induced hyperhomocysteinemia in Parkinson's disease: Elephant in the room
    Paul, Rajib
    Borah, Anupom
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (09): : 1989 - 1997
  • [32] The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease
    Heikkinen, H
    Nutt, JG
    LeWitt, PA
    Koller, WC
    Gordin, A
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (03) : 150 - 157
  • [33] Conversion of L-dopa to Extended Release L-dopa (Rytary®) in Patients with Fluctuating Parkinson's Disease: Predictors of Dose
    Ondo, William
    Coss, Pablo
    Christie, Melissa
    Pascual, Belen
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (01) : 153 - 156
  • [34] EFFECT OF L-DOPA ON DEMENTIA-RELATED RIGIDITY
    DURET, M
    GOLDMAN, S
    MESSINA, D
    HILDEBRAND, J
    ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 (01): : 64 - 67
  • [35] Interactions between cognition, depression and L-dopa in Parkinson's disease
    Degroot, C.
    Bruneau, M. A.
    Mejia-Constain, B.
    Bedetti, C.
    Monchi, O.
    MOVEMENT DISORDERS, 2012, 27 : S280 - S280
  • [36] L-DOPA in Parkinson's Disease: Looking at the "False" Neurotransmitters and Their Meaning
    Chagraoui, Abdeslam
    Boulain, Marie
    Juvin, Laurent
    Anouar, Youssef
    Barriere, Gregory
    De Deurwaerdere, Philippe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [37] L-dopa plasma levels and executive functions in Parkinson's disease
    Albani, G.
    Cattaldo, S.
    Mori, I.
    Pignatti, R.
    Pradotto, L.
    Mauro, A.
    MOVEMENT DISORDERS, 2009, 24 : S289 - S289
  • [38] Pupillometry as an indicator of l-DOPA dosages in Parkinson’s disease patients
    O. Bartošová
    C. Bonnet
    O. Ulmanová
    M. Šíma
    F. Perlík
    E. Růžička
    O. Slanař
    Journal of Neural Transmission, 2018, 125 : 699 - 703
  • [39] The Effect of L-dopa on Postural Stability in Parkinson's Disease Patients
    Wilczynski, Jacek
    Habik, Natalia
    APPLIED SCIENCES-BASEL, 2019, 9 (03):
  • [40] L-dopa therapy for Parkinson's disease: Past, present, and future
    Nagatsu, Toshiharu
    Sawada, Makoto
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S3 - S8
12345